ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Ophthalmology

Top Ophthalmology Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL KOREY M.D.

Ophthalmology

9,480

$715K

1168
1055 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

56%
prescriptions for brand name drugs

Avg: 63%

$75
Average prescription price

Avg: $77

MARIANNE FEITL MD

Ophthalmology

6,845

$423K

759
718 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

49%
prescriptions for brand name drugs

Avg: 63%

$62
Average prescription price

Avg: $77

SVETLANA TSIPURSKY

Ophthalmology

6,743

$547K

601
561 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 63%

$81
Average prescription price

Avg: $77

DAVID GREENBERG MD

Ophthalmology

6,657

$557K

753
712 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 63%

$84
Average prescription price

Avg: $77

NIKHIL WAGLE MD

Ophthalmology

5,740

$547K

861
803 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

78%
prescriptions for brand name drugs

Avg: 63%

$95
Average prescription price

Avg: $77

JOHN RHODE M.D.

Ophthalmology

5,723

$379K

911
835 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

51%
prescriptions for brand name drugs

Avg: 63%

$66
Average prescription price

Avg: $77

ROBERT BARNES MD

Ophthalmology

5,342

$449K

900
808 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 63%

$84
Average prescription price

Avg: $77

EDWARD SUNG M.D.

Ophthalmology

5,303

$384K

658
623 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 63%

$72
Average prescription price

Avg: $77

RICHARD QUINONES MD

Ophthalmology

4,658

$363K

550
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 63%

$78
Average prescription price

Avg: $77

HAN LIM MD

Ophthalmology

4,190

$251K

884
831 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 63%

$60
Average prescription price

Avg: $77

PATRICK BUTLER M.D.

Ophthalmology

4,078

$327K

761
675 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

69%
prescriptions for brand name drugs

Avg: 63%

$80
Average prescription price

Avg: $77

GREGORY NELSON

Ophthalmology

4,050

$336K

786
745 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 63%

$83
Average prescription price

Avg: $77

FREDERICK RAUSCHER MD

Ophthalmology

4,049

$254K

589
497 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

52%
prescriptions for brand name drugs

Avg: 63%

$63
Average prescription price

Avg: $77

JOHN KAY MD

Ophthalmology

4,028

$169K

894
818 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

57%
prescriptions for brand name drugs

Avg: 63%

$42
Average prescription price

Avg: $77

BART JONES M.D.

Ophthalmology

4,015

$351K

901
837 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

82%
prescriptions for brand name drugs

Avg: 63%

$88
Average prescription price

Avg: $77

EDWARD DOISY III M.D.

Ophthalmology

3,891

$324K

695
672 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

67%
prescriptions for brand name drugs

Avg: 63%

$83
Average prescription price

Avg: $77

SMAJO OSMANOVIC M.D.

Ophthalmology

3,854

$215K

702
647 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 63%

$56
Average prescription price

Avg: $77

JOHN CHU MD

Ophthalmology

3,842

$194K

644
607 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

51%
prescriptions for brand name drugs

Avg: 63%

$51
Average prescription price

Avg: $77

STEVEN BROWN M.D, FACS

Ophthalmology

3,755

$300K

734
710 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

65%
prescriptions for brand name drugs

Avg: 63%

$80
Average prescription price

Avg: $77

TAMARA WYSE MD

Ophthalmology

3,600

$385K

704
667 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

70%
prescriptions for brand name drugs

Avg: 63%

$107
Average prescription price

Avg: $77

CALVIN GRANT M.D.

Ophthalmology

3,577

$368K

449
370 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 63%

$103
Average prescription price

Avg: $77

STEPHEN GIESER M.D.

Ophthalmology

3,506

$339K

493
450 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

78%
prescriptions for brand name drugs

Avg: 63%

$97
Average prescription price

Avg: $77

MILDRED OLIVIER MD

Ophthalmology

3,470

$265K

476
429 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 63%

$76
Average prescription price

Avg: $77

DAVID GIESER M.D.

Ophthalmology

3,281

$297K

415
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 63%

$90
Average prescription price

Avg: $77

MICHAEL SAVITT MD

Ophthalmology

3,168

$307K

543
500 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

75%
prescriptions for brand name drugs

Avg: 63%

$97
Average prescription price

Avg: $77

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank